Males with sickle cell disease have higher risks of cerebrovascular disease, increased inflammation and a reduced response to hydroxyurea

Abstract

Biological sex is important. Male sex is associated with worse outcomes in most measures, including cerebrovascular disease, hospital admissions, and blood transfusions, but not survival. Females also appear to have a better response to hydroxyurea therapy, reduced markers of inflammation, and better liver function.